{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/ankylosing-spondylitis/diagnosis/investigations/","result":{"pageContext":{"chapter":{"id":"ea0d0799-6976-5240-92c5-4623f9074fda","slug":"investigations","fullItemName":"Investigations","depth":2,"htmlHeader":"<!-- begin field 6d92e9e0-7d36-442d-8328-a28d71932159 --><h2>What investigations should I arrange when ankylosing spondylitis is suspected?</h2><!-- end field 6d92e9e0-7d36-442d-8328-a28d71932159 -->","summary":"","htmlStringContent":"<!-- begin item ed07ad3a-34c8-40da-9dae-f97b9989b9d9 --><!-- begin field 50027981-e7ae-4303-9c25-cfe88c89c8a5 --><ul><li><strong>Spondyloarthritis cannot be reliably diagnosed or ruled out by a single test. </strong><ul><li><strong>Consider testing for erythrocyte sedimentation rate (ESR), and/or C-reactive protein (CRP).</strong><ul><li>Be aware that a diagnosis of spondyloarthritis should not be ruled out if CRP and ESR are normal.</li></ul></li><li><strong>Follow local referral protocols on imaging the sacroiliac joints and spine, or seek specialist advice on imaging before referral. </strong><ul><li><strong>X-rays. </strong>Ankylosing spondylitis is suggested by X-ray changes of the sacroiliac joints and spine, including sacroiliitis, sclerosis (thickening of bone), erosions, and partial or total ankylosis (fusion of joints).</li><li><strong>Magnetic resonance imaging (MRI). </strong>In some people with symptoms of ankylosing spondylitis, inflammation of the sacroiliac joints can be detected on MRI despite an absence of changes on X-ray. The use of MRI has enabled an increase in detection of sacroiliitis and inflammatory back pain and the diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/background-information/definition/\">non-radiographic axial spondyloarthritis</a>.  </li></ul></li><li><strong>HLA-B27 </strong>— if available, perform an HLA-B27 test in primary care only if a person has exactly three <a class=\"topic-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/management/suspected-ankylosing-spondylitis/#referral\">referral criteria</a>, to help determine whether referral to a rheumatologist is necessary.</li></ul></li></ul><!-- end field 50027981-e7ae-4303-9c25-cfe88c89c8a5 --><!-- end item ed07ad3a-34c8-40da-9dae-f97b9989b9d9 -->","topic":{"id":"228aa309-0970-5ae0-a937-1a670214e066","topicId":"0752afda-bf5b-48c4-b4af-e842f0a9b229","topicName":"Ankylosing spondylitis","slug":"ankylosing-spondylitis","lastRevised":"Last revised in May 2019","chapters":[{"id":"1318829b-e445-59f5-8079-ced63414cf7e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"28658e82-53d5-5798-84bf-7e67cc233b06","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"bc7876cf-e413-557d-b763-1b8198ae3cb7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b83be00a-c774-50aa-b8be-a04912f19bd5","slug":"changes","fullItemName":"Changes"},{"id":"ecb29915-59e9-5752-9bbb-fc44515688b3","slug":"update","fullItemName":"Update"}]},{"id":"81161324-4d7b-5419-85a9-dae9f57fa83b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c127b8df-f565-5637-adb8-bafbfd767c40","slug":"goals","fullItemName":"Goals"},{"id":"091c0d27-63a5-548e-8f08-5bfb48e416a7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f9ca120c-2183-5429-9706-101fc20540e1","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"58752ac1-77db-5b74-8e2e-bf0081dd74fd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ffa55c0b-7b3d-583c-8a67-f0372230cbf9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4c33c07f-65b3-572b-b4c0-1eecffd16191","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f4a7a8d2-8847-5779-9892-e4867ecaacdd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"8c9e7d3f-07eb-5b06-9f42-67f6c18e4ce2","slug":"definition","fullItemName":"Definition"},{"id":"64b026f5-a69f-5ef8-800d-7aee9ac65509","slug":"causes","fullItemName":"Causes"},{"id":"fc3d12c0-7b54-576d-ba75-e8570df23bf0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ff462ad5-64de-5366-801e-9806962bcf65","slug":"complications","fullItemName":"Complications"},{"id":"76129f0b-5489-511d-bc1d-565b990f4fb8","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a54d37d1-407b-50c4-b5e8-c98891ee1e00","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6a2b7eca-b47b-5a11-9909-91a6aea6835a","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"ea0d0799-6976-5240-92c5-4623f9074fda","slug":"investigations","fullItemName":"Investigations"},{"id":"58c6e66c-a8a5-56c9-8c47-7127807d9c73","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"5f2d8235-d927-54d7-bd0a-4ec15e3336b8","fullItemName":"Management","slug":"management","subChapters":[{"id":"0a3569b1-7ede-51ad-abdd-77173b02733e","slug":"suspected-ankylosing-spondylitis","fullItemName":"Scenario: Suspected ankylosing spondylitis"},{"id":"3e6db8e8-b2dc-5a7a-9fe2-0a341c7c963d","slug":"confirmed-ankylosing-spondylitis","fullItemName":"Scenario: Confirmed ankylosing spondylitis"}]},{"id":"b82cc559-18dd-500a-add0-dde6d8b59e63","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"76b292a6-865e-5dcd-9885-3e235e7664a4","slug":"oral-nsaids","fullItemName":"Oral NSAIDs"},{"id":"113dcc0f-4841-54a0-9101-a64009316e7c","slug":"proton-pump-inhibitors-ppis","fullItemName":"Proton pump inhibitors (PPIs)"},{"id":"52667269-49b0-5132-839c-67d58b9480db","slug":"paracetamol-codeine","fullItemName":"Paracetamol and codeine"}]},{"id":"59c2b871-f61e-5fb4-a894-cae5bdeda4bd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"80288a50-5bef-5779-8bf9-7d8abf169080","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"932977c5-3d44-5c3b-8787-7de309af3820","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"eb5fa8b8-2845-567c-ab0a-2274329dfc51","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c4153414-1fd0-5779-a348-78ee4ab85730","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"12b49dd2-6a18-5e19-8960-15901b6a91b7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"83d1e8ec-8cac-5c4a-ac1b-758b9b2501bb","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"67d800ae-fb2a-559a-89de-a4813d740021","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a54d37d1-407b-50c4-b5e8-c98891ee1e00","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"8b12177f-7862-5167-bd82-5a8bcdc57c6a","slug":"basis-for-recommendation-82b","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 27d9bdf9-2780-4737-b731-cc875825ec1f --><h3>Basis for recommendation</h3><!-- end field 27d9bdf9-2780-4737-b731-cc875825ec1f -->","summary":null,"htmlStringContent":"<!-- begin item 82ba608d-fc47-4659-aa5f-e3d9210efd59 --><!-- begin field 6deb3602-0e19-4d22-b78d-bcf416372c17 --><h4>Not diagnosing or ruling out spondyloarthritis on the basis of a single test</h4><ul><li>This reminder reflects information in a summary of the National Institute for Health and Care Excellence (NICE) guideline <em>Spondyloarthritis in over 16s: diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">McAllister et al, 2017</a>] and the NICE quality standard on spondyloarthritis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2018</a>].</li></ul><h4><strong>Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP)</strong></h4><ul><li>The guideline development group of the NICE guideline <em>Spondyloarthritis in over 16s: diagnosis and management</em> discussed that erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing may be used as part of the diagnosis of spondyloarthritis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017b</a>]. However, spondyloarthritis should <em>not</em> be ruled out on the basis of a negative result because not everyone with axial spondyloarthritis will have raised inflammatory markers [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2018</a>]. </li></ul><h4>Imaging of the sacroiliac joints and spine</h4><ul><li>For <em>specialist care</em> settings, NICE recommends offering plain film x-ray of the sacroiliac joints for people with suspected spondyloarthritis (unless they are likely to have an immature skeleton), and unenhanced MRI using an inflammatory back pain protocol if the plain film x-ray does not show sacroiliitis meeting modified New York criteria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017a</a>]. <ul><li>X-ray was recommended as first-line imaging by the NICE guideline development group because of its accessibility and the fact it can be used to diagnose ankylosing spondylitis. MRI was considered to be appropriate for suspected axial spondyloarthritis if sacroiliitis was not detectable on x-ray [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017b</a>]. Detail on the use of imaging and its findings is also based on a NICE technology appraisal [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2016</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">Taurog et al, 2016</a>]. </li></ul></li></ul><h4>HLA-B27 testing</h4><ul><li>NICE noted that the availability of HLA-B27 testing may vary depending on locality in primary care. However, the guideline development group felt that, if available, its use would be appropriate in a primary care setting to enable a final decision about referral in a small, selected group, as the test should not perform differently and interpretation of the result should be straightforward [<a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/ankylosing-spondylitis/references/\">NICE, 2017b</a>].</li></ul><!-- end field 6deb3602-0e19-4d22-b78d-bcf416372c17 --><!-- end item 82ba608d-fc47-4659-aa5f-e3d9210efd59 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}